论文部分内容阅读
目的:探讨液基细胞联合阴道镜检查在宫颈病变筛查中的价值。方法:选择2007年1月至2011年12月在我院妇产科门诊应用液基细胞联合阴道镜检查筛查宫颈病变的1771例患者为研究对象,对其结果进行回顾性分析。结果:对本组1771例患者进行液基细胞检查,采用TBS分类,共检出阳性涂片71例,其中,ASCUS50例,占2.8%;LSIL10例,占O.6%;HSIL10例,占O.6%;SCC1例,占0.07%。共行阴道镜检查506例,其中173例为镜下活检,病检结果显示:L-SIL级者17例,H-SIL:CIN2级者7例,CIN3级者4例(包括原位癌2例,浸润癌1例)。结论:液基细胞联合阴道镜检查是目前进行宫颈病变筛查的重要方法。
Objective: To investigate the value of liquid-based cells combined with colposcopy in the screening of cervical lesions. Methods: From January 2007 to December 2011 in our hospital obstetrics and gynecology outpatient application of liquid-based cells combined with colposcopy screening of cervical lesions in 1771 patients for the study, the results of a retrospective analysis. RESULTS: A total of 7171 smear-positive specimens were obtained from 1771 patients in our study. Totally 71 positive smears were obtained, of which 50 were ASCUS, accounting for 2.8%; 10 were LSIL, accounting for 0.6%; and 10 were HSIL. 6%; SCC1 cases, accounting for 0.07%. A total of 506 colposcopy colposcopy, of which 173 cases were microscopic biopsy, pathological examination showed: L-SIL grade in 17 cases, H-SIL: CIN2 grade in 7 cases, CIN3 grade in 4 cases (including carcinoma in situ 2 Cases, invasive carcinoma in 1 case). Conclusion: Liquid-based cells combined with colposcopy is an important method for screening cervical lesions.